SAN CARLOS, Calif., June 12, 2019 (GLOBE NEWSWIRE) — BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the China National Intellectual Property Administration has recently issued the Company Patent No: ZL 2014 8 00125575 for “Target Site Selection, Entry and Update […]
Other News
Transseptal Solutions Announces First Clinical Use of TSP Crosser™ in the United States
NETANYA, Israel, June 12, 2019 /PRNewswire/ — Transseptal Solutions Ltd., developer of an innovative Transseptal Access System with a novel approach of transseptal puncture and left atrial navigation, announced today the completion of the first TSP Crosser™ transseptal puncture procedure in the US. The procedure was successfully performed by Dr. Latib, the New Medical Director of […]
Merit Medical Awarded Interventional Fluid Management Agreement With Premier
SOUTH JORDAN, Utah, June 11, 2019 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has been awarded a group purchasing […]
CorMatrix® Cardiovascular, Inc. receives FDA 510(k) clearance to market the Cor™ PATCH epicardial patch for tissue support and repair in adult patients
ATLANTA, June 11, 2019 /PRNewswire/ — CorMatrix® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced FDA 510(k) clearance for the Cor™ PATCH. The Cor™ PATCH is indicated for epicardial tissue support and repair in adult patients. The Cor™ PATCH epicardial patch is the first epicardial cardiovascular medical device composed of first next […]
Aurora Resurgence Announces Sale of Cardiac Science Corporation to ZOLL Medical Corporation
LOS ANGELES, June 11, 2019 /PRNewswire/ — Aurora Resurgence, a Los Angeles-based private equity firm, today announced that its affiliate has entered into a definitive agreement to sell Cardiac Science Corporation (“Cardiac Science” or “CSC”), a leading provider of automated external defibrillators (“AEDs”), related services and accessories, to ZOLL® Medical Corporation, an Asahi Kasei […]
Shockwave Appoints Hajime Tada as General Counsel
SANTA CLARA, Calif., June 10, 2019 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Hajime Tada as General Counsel. From 2017 to 2019, Mr. Tada was […]
BioSig Technologies Set to Join Russell 3000® Index
Santa Monica, CA, June 10, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the company is set to join the broad-market Russell 3000® Index at the […]
Zoll Introduces New Technology to Improve the Management of Acute Heart Failure Patients
CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, announced the launch of and first patient prescription for the ZOLL µCor™ (pronounced “Micro Core”) Heart Failure and Arrhythmia Management System (HFAMS), designed to help clinicians improve outcomes and reduce hospitalizations for […]
Endologix Announces Reinstatement of CE Mark for its Nellix EndoVascular Aneurysm Sealing System
IRVINE, Calif.–(BUSINESS WIRE)–Endologix® Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the EC Certificate of Conformity (CE Mark) for the Nellix EndoVascular Aneurysm Sealing System (Nellix System) has been reinstated by GMED, the EU Notified Body for the Nellix System. The reinstatement […]
Precision Wellness Validates Performance of Predictive Risk Models to Power Precision Health
PALO ALTO, Calif.–(BUSINESS WIRE)–Precision Wellness, Inc. a Silicon Valley-based company at the intersection of next-generation AI, big data analytics and the latest medical science, today announced the validation of its cardiometabolic disease (CMD) predictive risk engine. The study was performed as part of a sponsored research with Stanford University to evaluate 416,936 […]
Recent
SCAI and CRT Announce Partnership to Advance Interventional Cardiology Education, Advocacy, and Research
Procyrion Appoints Andrew Davis as Chief Commercial Officer
SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI
Popular
- No commented posts yet